Why is the combination of RECAF with other markers "old news"? As mcd2inga stated, it has been announced before. It was not in 2006 as I first thought, it was way back in 2004.
"Moreover, combining the PSA and RECAF tests could eliminate the false positives resulting from using PSA testing alone. PSA has the advantage of localizing the problem to the prostate and RECAF could then determine if the high PSA value is due to a cancer. This combination would also facilitate the introduction of RECA into the market place since PSA testing is very common. The company is discussing such a combination of tests with major healthcare companies and laboratories presently performing PSA tests".
This is definitely not a new idea and was likely the original intent of Abbott before they decided to not proceed with RECAF. In 2004, from the above statement, Moro apparently got nowhere in discussions with other companies regarding the combination of markers.
Of all the markers currently in use, PSA is probably the most tissue specific marker and would not still leave you wondering where the cancer was like the other markers.
